calcipotriol spray (CD 2027) / Nestle - LARVOL DELTA

"Reflecting on an extraordinary #WCD2023, we’d like to extend a big thank you to our team and participants.​ Missed out? Don’t worry, stay connected for more insights! @wcd2023sg @wcd2027munich" (@VichyPro)

"It’s just getting started @ILDSDerm @wcd2027gdl #WCD2023Singapore" (@wcd2023sg)

"We will host the WCD 2027! We are thankful for all your support! See you on WCD 2027! Here at Guadalajara!! #wcd2027gdl #wcd2023singapore #wcd2023 #ildsderm" (@wcd2027gdl)

"Experience a virtual walkthrough of our innovative Vichy booth at #WCD2023Singapore! Check out the insightful video below from our Brand President, providing a comprehensive tour of our dedicated space. #WCD2023 @wcd2023sg @wcd2027munich" (@VichyPro)

Video

"Our two candidate cities for the next WCD: Munich & Guadalajara! Vote for which city you think will win the bud in the comments below👇👇👇 @wcd2027munich @wcd2027gdl #WCD2023Singapore" (@wcd2023sg)

"Hochkarätiges Treffen bei der AAD in New Orleans: Das Bidding Committee für den Weltkongress 2027 geformt von den 3 deutschsprachigen dermatologischen Gesellschaften @ddg_derma, ÖDGV, SGDV! Support Munich 2027! #aad2023 #dermatology #wcd2027" (@oegdv)

Dermatology

Galderma, world’s leading company focused exclusively on dermatology, acquires Spirig (Business Wire) - "Galderma Pharma S.A...and Spirig Pharma A.G. (“Spirig”), a leading company in the development, production, and marketing of dermatological products, today announced that they have entered into a definitive agreement under which Galderma will acquire Spirig."

Licensing / partnership • Psoriasis

Lipidor announces enrolment of last patient in Calcipotriol/Akvano spray (AKP01) phase III study targeting psoriasis (PRNewswire) - "Lipidor AB (publ) today reports that the last patient has been enrolled in the ongoing phase III study using calcipotriol spray against mild to moderate psoriasis. Results from the study are expected to be presented in December 2019."

Enrollment status • P3 data